Myriad(MYGN) - 2020 Q1 - Quarterly Report
Myriad(MYGN)2020-05-06 09:58
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-26642 MYRIAD GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0494517 (State or other jurisdicti ...